Navigation Links
Oncologists Will Be More Aggressive In Adopting Biosimilars Compared With Other Specialties
Date:9/28/2010

BURLINGTON, Mass., Sept. 28 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that oncologists will be the most aggressive in adopting biosimilars compared with other specialties because of their lower clinical trial requirements. According to Biosimilars Advisory Service: Physician Perspectives on Biosimilar G-CSFs and MAbs in Oncology, Decision Resources expects biosimilar versions of granulocyte colony-stimulating factor (G-CSF) and monoclonal antibody (MAb) therapies used in oncology to erode more than $7 billion in brand sales in 2019 alone across the U.S., EU5 (France, Germany, Italy, Spain and United Kingdom) and Japan markets.

Primary research reveals U.S oncologists in particular will more rapidly adopt biosimilars compared to their European counterparts. Compared with French and German oncologists, U.S. oncologists will require fewer and shorter Phase III clinical trials before they feel comfortable prescribing biosimilars. The majority of surveyed U.S. oncologists would require one trial lasting 12 months or less for biosimilar G-CSFs and at most two clinical trials lasting two years or less for biosimilar MAbs before they feel comfortable prescribing biosimilars. Surveyed solid-tumor oncologists across countries have higher expectations for clinical trials of biosimilar MAbs than for biosimilar G-CSFs.

Across the U.S., France and Germany, the majority of surveyed oncologists expect to begin prescribing biosimilars within 12 months after launch, contributing to the rapid erosion of branded G-CSFs and MAbs.

"Because of patent expiries and more established regulatory pathways for approving biosimilars in Europe, most biosimilar MAbs will launch in the EU5 before the United States," said Decision Resources Analyst Cindy Fung, Ph.D. "As a r
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions
2. Vermillion Receives Award From the Society of Gynecologic Oncologists
3. News Media Advisory: Worlds Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments
4. Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer
5. Society of Gynecologic Oncologists 40th Annual Meeting on Womens Cancer to Include Sessions on Robotics Surgery
6. SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists
7. Society of Gynecologic Oncologists Issues White Paper on HPV Vaccines Impact on Cervical Cancer Prevention
8. Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer
9. US Oncology Launches New Flexible Options for Community Oncologists to Join the United Network of US Oncology
10. For Treatment of Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia, 41 Percent of Surveyed European Hematologist-Oncologists Say MabTheras Favorable Efficacy Profile is the Most Significant Driver of Their Use of This Agent
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 20, 2015 Kalorama Information says that ... to be robust; the market is driven by ... global markets, new product innovations and increasing life ... market inhibitors, such as government restraints, limited hospital ... The healthcare market research publisher,s report, Insulin ...
(Date:4/20/2015)... , April 20, 2015  Published results ... trends in the ability of Neuraltus Pharmaceuticals ... of amyotrophic lateral sclerosis (ALS, also known as ... treatment period. While NP001,s slowing of decline in ... was not statistically significant, clinically meaningful slowing of ...
(Date:4/20/2015)... ADDISON, Texas , April 20, 2015 /PRNewswire/ ... have entered a settlement agreement with Inter-Mountain Capital ... with a warrant exercise. Under ... 361,516 shares of Common Stock, issued an unsecured ... Warrant to purchase 194,118 shares of Common Stock ...
Breaking Medicine Technology:Kalorama: Insulin Pump Market Growing Robustly 2Kalorama: Insulin Pump Market Growing Robustly 3Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 2Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 3Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 4Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 5ULURU Inc. Announces the Settlement of Outstanding Litigation 2
... ANGELES, Jan. 5, 2012 /PRNewswire-iReach/ -- Gentech Pharmaceutical, ... Golden Globe Awards introducing new products and giving away freebies ... include its flagship weight loss product, PhenTabz as part of ... celebrities at the upcoming Golden Globe awards in the GBK ...
... /PRNewswire-iReach/ -- FutureNet,s Ambulatory Electronic Health Record ... stamp of approval by earning ONC-ATCB certification. The ... of enabling ambulatory/outpatient providers to qualify for funding ... Tested and certified under the Drummond Group,s Electronic ...
Cached Medicine Technology:Golden Globe Awards Adds Gentech Pharmaceutical as New Participating Sponsor 2FutureNet Granted Certification for Cloud-based Ambulatory EHR 2FutureNet Granted Certification for Cloud-based Ambulatory EHR 3
(Date:4/21/2015)... On Saturday, May 2nd, 2015, board ... his team from Georgia Eye Physicians and Surgeons ... Now, being held in Piedmont Park by the Lupus ... be the largest LFA-sponsored walk in the nation, hosting ... funds and awareness for lupus, an unpredictable and potentially ...
(Date:4/21/2015)... “The warm summer season is fast approaching,” says Marta ... younger than her age? In the ongoing battle against ... Signs of premature aging are deep wrinkles and unsightly ... spent in the sun without adequate protection.” , Outward appearances ... dangers of UV rays can go deep below the surface. ...
(Date:4/20/2015)... (PRWEB) April 21, 2015 Using Quality ... CMOs Speed Production and Improve Compliance , **FDAnews Webinar**, ... EDT, http://www.fdanews.com/qualitybydesign , The life sciences industries ... them to do more with less. Mergers, acquisitions, ... CMOs to finds ways to speed up production while ...
(Date:4/20/2015)... City, NY (PRWEB) April 21, 2015 ... as a 2015 Professional Woman of the Year. Ms. ... in healthcare. As the largest, most-recognized networking organization of ... and profession, the National Association of Professional Women is ... and over 200 local chapters. , “We are like ...
(Date:4/20/2015)... 20, 2015 The NFL draft season is ... players to add to their rosters, both for their skills ... this episode of SCI TV , Vinnie Iyer ... of Greg Hardy given increased attention on off-field conduct in ... after the Ray Rice scandal brought media scrutiny, once again, ...
Breaking Medicine News(10 mins):Health News:9th Annual Walk to End Lupus Now 2Health News:9th Annual Walk to End Lupus Now 3Health News:Sun’s the Word this Mother’s Day Say’s SunGrubbies.com, a Leading Retailer of Sun Protection Products 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 3Health News:National Association of Professional Women Announces Suzanne Webb, Chief Executive Officer at Exclusive Surgeries Network, LLC, a 2015 Professional Woman of the Year 2Health News:Character Concerns in the NFL with Vinnie Iyer on SCI TV 2
... surveillance is an acceptable alternative to surgical excision in ... without cell abnormalities, a new study shows. , The ... Pacific Medical Center in San Francisco, included 119 papillomas ... follow-up of a minimum of two years without surgical ...
... 2 (HealthDay News) -- Aspirin is just as effective as ... failure patients with a normal heart rhythm, a landmark ... researchers from Columbia University in New York City said their ... because it is much cheaper. The 10-year study was ...
... the University of California, Davis, are among 12 scientists ... Hartwell Foundation this year. The awards provide $100,000 of ... well as videoconferencing equipment for periodic communications with the ... funding a UC Davis Hartwell Foundation postdoctoral researcher with ...
... West Orange, NJ. May 2, 2012. Kessler Foundation will be ... on Cognition in Multiple Sclerosis to be held at the ... 2012. John DeLuca, PhD, the Foundation,s VP of Research and ... Strober, PhD, and James Sumowski, PhD. Kessler Foundation ...
... - The University of Texas MD Anderson Cancer Center President ... of Sciences (NAS) - one of the most prestigious accolades ... and engineering. DePinho is the first member of the ... The NAS is a private, nonprofit society of distinguished ...
... NY(May 1, 2012) Large majorities of older Americans ... according to a new national survey, "How Does It ... by the John A. Hartford Foundation, a champion for ... Institute for Geriatric Nursing at New York University,s College ...
Cached Medicine News:Health News:Surgical excision unnecessary in some patients with benign papillomas 2Health News:Aspirin as Effective as Warfarin for Heart Failure: Study 2Health News:Biomedical researchers receive Hartwell Foundation awards 2Health News:Biomedical researchers receive Hartwell Foundation awards 3Health News:UT MD Anderson President Ronald DePinho elected to National Academy of Sciences 2Health News:National poll: Low cost, lifesaving services missing from most older patients' health care 2Health News:National poll: Low cost, lifesaving services missing from most older patients' health care 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: